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Abstract 
Several microbial communities colonize different body areas constituting the human microbiota. 
In recent years, several researches suggested the involvement of these bacteria in maintaining 
homeostasis of the human body, highlighting as a microbial dysbiosis may be implicated in 
numerous inflammatory conditions and human diseases. Although “dysbiosis” is referred to an 
alteration of the “normal microbiota community structure”, to date there is not a specific microbial 
composition, definable as “normobioma”, that can characterize and identify a physiological 
microbiome. The development of high-throughput sequencing technologies and their application 
to the study of human microbiome allowed the achievement of important results about the 
interactions between microorganisms and the host. Moreover, metagenomics studies extended 
scientists’ knowledge about the human microbiota and its implications in numerous human 
diseases. Since the 16S rRNA gene sequencing was shown to be an effective method to investigate 
microbial communities, recently our laboratory adopted this molecular approach to characterize 
the interactions between bacteria and host. Therefore, the present PhD work describes our 
experience in samples collection, experimental procedures and data analysis in studying the human 
microbiota by means of a metagenomics approach. Indeed, our studies allowed us to understand 
that first of all, the study population should be well characterized using specific and very strict 
inclusion and exclusion criteria. In particular, to achieve a complete overview of microbial 
communities involved in a specific fisio-pathological condition, a standardization of experimental 
protocols and data analysis should be adopted to carry out metagenomics surveys. Moreover, the 
taxonomic evaluations through 16S rRNA gene sequencing are just a first step for elucidating the 
roles of bacteria in the host’s health. Indeed, the study and analysis of microbial networks should 
be usually adopted to clarify and better understand the interactions between microorganisms.  
Finally, integrating the metagenomics data which those obtained by metatranscriptomic, 
metaproteomic, and metametabolomic represents a promising approach to develop new 
noninvasive bacterial-related diagnostic tools. 
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Chapter 1  
AIM OF THE STUDY  
The main objective of the present PhD study was the characterization of human microbiota by 
means of a Next Generation Sequencing approach. In particular, the research activities were 
focused on the application and study of different analytic methods useful to investigate and better 
characterize the human microbiota. The final goal was to improve and deepen our skills and 
knowledge about interactions between bacteria and host and to evaluate a potential application of 
metagenomics in clinical microbiology.  
Consequently, the first part of this thesis gives an introduction about human microbiota and the 
methodology used to sequence biological samples. Results and manuscripts realized during the 
PhD period are included in the present work, while general considerations and conclusions about 
the characterization and analysis of human microbiota are discussed in the conclusive part. 
 3 
 
Chapter 2  
INTRODUCTION  
2.1 Human microbiota  
The human microbiota consists of an incredibly rich and diverse set of microbial populations living 
in symbiosis with the host organism and colonizing numerous districts of human body including 
the gut, skin, urogenital tract, oral and nasopharynx cavity. In the last years, numerous studies 
highlighted its importance for the overall human health. Indeed, today human microbiota, and in 
particular intestinal and cutaneous ones, is considered the "health organ" since it is involved in 
different protective, structural and metabolic processes essential for the maintenance of human 
health. For instance, intestinal bacteria allow the exploitation of numerous food substances that 
otherwise human enzymes would not be able to digest. In addition, these microorganisms stimulate 
host's immune system contributing to its defense against potentially pathogenic bacteria. 
It has been suggested that each individual acquires his own microbiota already during the 
gestational period, when maternal microorganisms colonize the fetus, reaching his intestinal 
environment [1]. Subsequently, after birth, newborn's microbiota is influenced by the different 
mode of delivery, environmental microorganisms and breastfeeding [2]. Several evidences 
highlighted that the microbial community contained in breast milk may carry out important 
functions in modulating both metabolic and immunological activities of newborn. Indeed, breast 
milk is considered essential not only to fulfil nutritional demands of the baby and enable his rapid 
growth, but especially to stimulate his immune system and transfer beneficial bacteria able to 
confer protection against potential pathogens. Therefore, a week after birth, newborn acquires a 
certain number of bacteria which constitute his first microbiota; this latter, will be strengthened 
and diversified during life. Consequently, bacterial colonization occurring in the first years of 
infant's life influences not only the composition of his transient microbiota but also the microbiota 
stability and composition during adulthood [3]. Figure 1 shows the possible immunological and 
microbial changes that characterize the dynamic development of human microbiota.
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Although the human microbiota is characterized by a very high level of biodiversity, we can 
distinguish a small number of species in common to all individuals which represent the 
phylogenetic core of human microbiota. The remaining portion, instead, is variable and it differs 
both between different populations and individuals belonging to the same ethnic group; this is due 
to different eating habits, genetic constitution, lifestyle, environmental and geographical 
conditions and at least, to the age of individuals. Just this variable component  ensures that each 
subject has his own and unique microbiome [4]. For this reason, some researchers dare to say that 
in the future we may be identified no longer through fingerprints but through our microbiota [5]. 
Therefore, as human microbiota consists in a vast “universe”, today numerous scientific fields are 
investing on its study and deep characterization. Today, most studies concerning the microbiota 
are focused on the bacterial community profiling; however, this approach results few useful to 
elucidate the mechanisms involved in the interaction and cross-talk with the host. The major 
challenge in evaluating host–microbiome metabolic interactions is understanding how this can 
affect the individual's health status. In this context, metaproteomics and metabolomics approaches 
may extend our knowledge on the functional role of the human microbiota and its interactions with  
 
Figure 1-Development process of the human microbiota   Figure source from article publish by 
Clemente JC et al. in Cell. 2012 Mar 16;148(6):1258-70.  
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the host, by using different methodologies such as shotgun proteomic, spectroscopy and mass 
spectrometry or liquid chromatography-mass. 
 
2.1.1 Gut microbiota  
Human gut harbors a huge amount of microorganisms, approximately 1019 bacteria. The main 
bacterial phyla are Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria and 
Verrucomicrobia. Nevertheless, the concentration of different bacterial genera and species  
 
composing the gut microbiota changes along the digestive tract, increasing exponentially from 
stomach to the descending colon [6]. These microorganisms carry out mainly a metabolic, trophic 
and protective activity [7]. Together, these three functions guarantee a correct absorption of 
nutrients and maintain the physiological gut permeability. 
Moreover, a correct balance within microorganisms composing the gut microbiota is essential to 
maintain the correct intestinal pH and control proliferation of potential pathogenic bacteria. 
Indeed, changes in its microbial composition may lead to an imbalance between the abundance of 
beneficial and harmful microorganisms. This condition, defined as dysbiosis, may favor host 
susceptibility to different diseases including metabolic disorders, such as obesity and diabetes, 
inflammatory bowel disease (IBD) and atopic diseases. 
Opportunistic bacteria, such as Escherichia coli, Clostridium spp. and Salmonella spp. can take 
advantage from aforementioned imbalance condition and cause severe pathologies. Conversely, 
other intestinal microorganisms are particularly beneficial for the host’ health. Among these, 
bacteria belonging to Lactobacillus and Bifidobacterium genera are considered the main probiotic 
microorganisms. They are able both to modulate intestinal microbiota composition and acidify  
intestinal environment thus reducing the incidence of infections [8]. Furthermore, intestinal 
probiotic bacteria act not only at  gastrointestinal level but also on host’s immune system; indeed, 
they are able to stimulate  production of anti-inflammatory cytokines, reducing the onset of 
respiratory infections and allergic diseases [9], [10]. Therefore, today it is clear that the human gut 
microbiota plays a crucial role in both the maintenance of gastrointestinal homeostasis and the 
overall host’s health.  
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2.1.2 Skin microbiota 
Although skin is a continuous tissue covering our whole body, it is characterized by a wide variety 
of habitats including invaginations and specialized niches with different ecology [11]. Each 
cutaneous district is controlled by different conditions of humidity, temperature, pH and sebum 
content that, depending on its position on human body, influence cutaneous bacterial colonization.  
 
Firmicutes, Bacteroidetes, Actinobacteria and Proteobacteria are the main bacterial phyla 
constituting the skin microbiota. The epidermis harbors mainly aerobic bacteria; among these, 
staphylococci (phylum Firmicutes), in particular Staphylococcus epidermidis, seem to be the main 
skin colonizers. Differently, a massive presence of facultative anaerobic bacteria belonging to 
Propionibacterium genus (phylum Proteobacteria) have been detected both in derma and regions 
with a high amount of sebum [12]. 
 
Skin surface, interposing itself as a barrier between the organism and external environment, 
protects host from the action of potential pathogens and harmful agents. However, the skin is not 
only the first line of defense but, thanks to its resident bacteria which constitute the skin 
microbiota, it is considered a dynamic organ whose structure, composition and function constantly 
changes during host’s life. Considering that, the physiology of infant and adult’s skin is widely 
different. 
Especially in the first years of life, baby's skin is more hydrated than that of an adult, having 
alkaline pH, increased desquamation, high cellular turnover and hair follicles secreting immature 
sebum. These features favor the colonization of numerous commensal bacterial species which 
contribute to both skin homeostasis and correct modulation of local immune responses. Moreover, 
it was demonstrated that bacterial species belonging to Staphylococcus genus are dominant in 
infant’s skin microbiota; nevertheless, their abundance decreases towards the end of child's first 
year of life who, already at 12-18 months old, shows a skin microbiota composition similar to that 
observed in adults [13]. 
 
The first year of life of each individual is characterized by an intense development of the whole 
organism that involves mainly the maturation of immune system. However, newborn’s skin 
physiology is still evolving and for this reason, if compared to adult skin, it may be  
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underperforming and more vulnerable to microbial infections and pathological conditions, such as 
atopic dermatitis and psoriasis [14]. Consequently, it is fundamental that a specific balance 
between skin barrier and cutaneous microorganisms is established to guarantee the maintenance 
of host’s health. 
 
2.1.3 Breast milk microbiota 
Human breast milk contains different bioactive molecules, necessary not only to feed the baby 
but also to protect him against infections or inflammations. Many of these factors, such as 
antimicrobial substances, hormones (cortisol) and smaller proteins (as epidermal growth factor, 
nerve growth factor, insulin like growth factor), may protect lactating mammary gland and 
strengthen newborn’s intestinal environment [17]. Moreover, recent studies showed that breast 
milk is not sterile as traditionally thought, but it represents a great source of commensal bacteria, 
including probiotic microorganisms, which may have a positive impact on newborn’s health, 
also contributing to the development of his immune system [9]. 
Human milk approximately contains 10³/10? colony forming units (CFU)/ml of bacteria [15]. 
Every day, the baby takes about 800 ml of milk, ingesting about 1x10?? - 1x10?CFU of 
microorganisms responsible for the formation of his initial gut microbiota. Bacteria contained in 
colostrum and mature milk play a pivotal role on infant’s health up to several months after his 
birth [9]. These microorganisms, indeed, may reduce the incidence and severity of several 
infections by competitive exclusion mechanisms and the production of antimicrobial compounds, 
such as bacteriocins [16]. Moreover, breast milk microbiota facilitates digestive processes favoring 
the metabolization of sugars and proteins [7, 16]. 
 
Interestingly, the presence of numerous Lactobacillus and Bifidobacterium strains in human milk 
is positively associated with beneficial effects on the host’s organism. These bacteria arouse great 
interest in the scientific community as they are the main probiotic microorganisms used worldwide 
[17]. The administration of probiotic supplements, for instance, may help to restore the milk 
microbiota balance after an intense use of antibiotics which can lead to bacterial dysbiosis [9]. 
Moreover, a decrease of lactobacilli in breast milk has been associated with increased  
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susceptibility to allergies and gastrointestinal disorders in newborns [18]. Therefore, 
microorganisms contained in human breast milk are essential to maintain a correct bacterial 
homeostasis and colonize infants’ gut [19]. In particular, the first gut microbiota colonization is 
influenced by both baby’s genetic features and the mode of delivery. Indeed, it is known that 
vaginal and fecal bacteria, such as bacteroides, bifidobacteria and lactobacilli, are acquired during 
the passage through the birth canal. Differently, the gut of infants born by Caesarean section is 
mainly colonized by environmental bacteria such as Clostridium difficile and Escherichia coli 
[20]. Also the nutritional characteristics of the human breast milk play a key role in the selection 
of the gut microbiota during early infancy. Indeed, the human breast milk has a dynamic 
composition that, in according with the time of lactation, changes during its transition from 
colostrum to mature milk [21]. Colostrum is produced immediately after the birth until the fifth 
postpartum day. It is characterized by a large amount of immunoproteins, such as lactoferrin, 
vitamins and immunostimulating components, as immunoglobulins A (IgA) and leukocytes, which 
facilitate both the development and maturation of the newborn’s immune system [22]. Differently, 
the mature milk is secreted at 10th day postpartum and if compared to the colostrum, it is 
characterized by a lower protein content but a higher abundance of fatty acids; oligosaccharides, 
in particular, represent their main component. The mature milk is also rich in glycans, including 
glycoproteins, mucins, glycosaminoglycans, and glycolipids. These bioactive compound promotes 
gut colonization by Bifidobacterium bifidum and contribute to the maturation of infant’s intestinal 
microbiota inhibiting the colonization by potential pathogens [23]. 
Therefore, it has been suggested that the  breast milk  microbiota composition may modulate a 
balanced  initial immune response and the development of immune-mediated diseases (asthma, 
inflammatory bowel disease, type 1 diabetes) during both  infancy and  adulthood [24]. For these 
reasons, the researchers nowadays agree that breastfeeding leads to several health benefits.  
 
2.2 Next generation sequencing technologies  
Sequencing technologies are relatively recent and they have a common “forefather”, the Sanger 
method, which represents the first generation of genomic sequencing; these technologies led to a 
great improvement of molecular biology, allowing the study of different types of nucleic acids  
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(DNA, RNA, cDNA, etc.). The high resolution, accuracy, and quality of data obtained with 
sequencing methods make them ideal to study the whole genomes, gene variants and also to  
 
identify numerous microbial pathogens [25]. The dynamic and rapid evolution of sequencing 
technologies allowed today their application in research and diagnostic laboratories. In medical 
field, for instance, they allow diagnosis of diseases related to genomic structure, highlighting a 
vision of "personalized medicine" thanks to the application of therapeutic strategies close to 
patients’ needs [26]. Nowadays, second-generation sequencing technologies, also defined as "Next  
 
Generation Sequencing" (NGS), consist in high-throughput sequencing systems. They allow to 
generate, simultaneously and in short time, millions of gene sequences constituting the genomic" 
library " [27]. Consequently, NGS technologies made possible to reduce drastically both time and 
costs of experimental setting. Moreover, the possibility to perform multiple analysis allows 
obtaining a huge amount of data in short time; consequently, it is necessary using innovative 
bioinformatics systems to manage all this new information [28]. In microbiology, the 
characterization of multiple bacterial DNA in a single biological sample allowed the development 
of a new study approach defined as Metagenomics. 
 
 
2.2.1 Metagenomics 
Metagenomics is an approach based on genome sequencing of all microorganisms colonizing the 
same habitat; accordingly, this method allows to bypass cultural isolation of bacteria assessing, 
instead, the microbial complexity in their natural environment [29]. 
To standardize the analytical method, metagenomics uses the amplification of 16S rRNA gene, 
which codes for a particular rRNA contained within the ribosomal small subunit.  
 
The 16S rRNA gene is selected mainly for two reasons: 
? it contains both stable and variables regions, these latter are species-specific (Figure 2); 
? 16S rDNA structure changes very slowly over the time and it is composed by 1500 highly 
conserved base pairs. Although, there are other genes coding for rRNA, these are not 
adequate to perform a metagenomics analysis. Indeed, 5S rRNA consists of 120 bp and 
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the information is thus limited; otherwise, the 23S rRNA consists of 2900 bp, thus it 
results too complex. 
 
 
Universal primers are used to recognize the highly conserved regions and allow the duplication 
and amplification of adjacent hypervariable regions useful for bacterial identification. 
Consequently, hypervariable regions can be considered as the "identity card" of bacteria. 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.2.2 Ion Torrent TM PGM sequencing 
Nowadays, numerous sequencing technologies allow the parallel analysis of several DNA 
samples. Among the different NGS platforms we can find the personal Genome Machines (PGMs), 
which are described as "benchtop" sequencing machines with all advantages of NGS technologies 
(speed and reduced costs of analysis) [30]. In particular, the Ion Torrent TM PMG (Life 
Technologies, Italy) platform is based on a semiconductor technology, which exploits in vitro the 
principle occurring in natural biological systems. Indeed, when a single nucleotide is incorporated 
in the new double-stranded DNA chain by the DNA polymerase enzyme, a hydrogen ion is 
released as byproduct [31].  
 
 
 
Figure 2 -16S rRNA gene illustrating the conserved (green) and variable (red) 
regions. Figure source from article publish by S. Chakvavorty et al in 
MolBiol(Mosk).2015 Sep-Oct;49(5):749-59. 
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The Ion Torrent technology is based on a sophisticated high-density array, with micro-wells inside 
of which the DNA synthesis and the consequent release of protons is cyclically repeated. Working 
as a pH meter, the machine records all pH changes generated during the nucleotides annealing, by 
the release of hydrogen ions (Figure 3). Therefore, Ion Torrent appears to be an innovative 
technology since it does not use fluorescent molecules which are commonly exploited by 
numerous sequencing machines; furthermore, this platform does not need further capture and 
analysis devices of fluorescence signal, being thus extremely smaller, faster in the timing 
processing and much less expensive than other NGS platforms [30, 31]. 
 
Using the HiSeq platform, for instance, the fluorescent signal decays after a certain number of 
cycles determining, as consequence, several analysis problems. Differently, signals detected by 
Ion Torrent ™ PGM tend to remain stable even after numerous cycles, thus realizing highly  
 
accurate analysis. Finally, a single sequencing run with Ion Torrent PGM requires a very small 
amount of DNA: 10 nanograms of sample are enough to get sequences (called "reads") of optimal 
length between 200 and 400 bp. For these reasons, in our laboratory, Ion Torrent technology is 
regularly applied to characterize the composition of human microbiota.  
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Figure 3-Figure reproduced from N.J. Clifton et al article publishes on 2013;1048:247-84. a) Ion 
Torrent sequencing; b) Semiconductor packing (on right), a chip section with the wells in evidence 
(on left); c)Chemical signal sensor to digital sequence; d)Pattern of chemical sequencing 
implemented in Ion Torrent; e) Signal processing by Ion Torrent technology. 
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Chapter 3 
MATERIALS AND METHODS  
3.1 Recruitment of subjects  
In vivo studies were carried out on human samples available from different scientific 
collaborations and they were used to determine the reciprocal influence between host and 
microbiota. 
3.2 Studying the human microbiota   
3.2.1 Bacterial DNA extraction and 16S rRNA Gene Amplification 
DNA was extracted from biological samples using different DNA Extraction Kits (Norgen, 
Thorold, Canada and Qiagen, Milano, Italy) following the manufacturer’s instructions. They are 
all  column-based DNA extractions kits which are strongly recommended for downstream 
sequencing [34]. 
Partial 16S rRNA gene sequences were amplified from extracted DNA using the 16S 
Metagenomics Kit (Life Technologies, Monza, Italy), designed for rapid analysis of polybacterial 
samples using the Ion Torrent sequencing technology. Kit includes two primer sets that selectively 
amplify corresponding hypervariable regions of bacterial 16S RNA gene:  
? primer set V2-4-8;  
? primer set V3-6, 7-9.  
For each sample 2 reaction mix were prepared. For PCR (Polymerase Chain Reaction) reaction 
was used a SimpliAmp Cycler ™ Thermal Cycler (Applied biosystems, Life Technologies, 
Monza, Italy) following temperature profile summarized in Table 3. A negative control was 
included to verify the absence of PCR reagents bacterial contamination. Integrity of PCR 
amplicons were analyzed by electrophoresis on 2% agarose gel. 
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3.2.2 Preparing genomic library  
PCR products were purified using Agencourt AMPure XP DNA purification beads (Beckman 
Coulter Genomics, Germany), in order to remove primer dimers according to the supplier’s 
instructions. Amplicons concentration was estimated (ng/µl) by means of Qubit system (Life 
Technologies, Monza, Italy) and libraries created by means of Ion Plus Fragment Library kit (Life 
Technologies, Monza, Italy). Table 4 summarizes the amount of reagents necessary for the 
purification of amplicons. 
 
 
 
 
 
 
 
 
 
For each sample, bacterial libraries were prepared using an optimal amount of purified amplicons 
(10-100 ng) quantified by mean of Qubit system (Life Technologies, Monza Italy). The protocol 
for library preparation provides the use of two different reaction mixtures obtained through the Ion 
Plus Fragmentary Library Kit (Life Technologies, Monza Italy). Table 5 reports the initial reaction 
mixture used to prepare the genomic library. 
 
 
Table 2- Quantities of reagents used for the 
reaction mixture.1V2-4-8 or V3-6,7-9 
Table 3- PCR conditions 
Table 4- Reaction mixture for the purification of the amplicon pool. 
1 Combine equal volume of the 2 reactions  
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The incubation of template at room temperature with End Repair enzyme allowed the 
“reconstruction” of amplicon 3' and 5' ends, which is necessary to anchor both adapters and 
barcode sequences. A further purification, by means of the Agencourt® AMPure® XPbeads, 
ensured the complete purification of fragments. 
Subsequently, barcodes were added to each sample using Ion Xpress Barcode Adapters 1–16 kit 
(Life Technologies, Italy). Table 6 shows the amount of reagents necessary to prepare the reaction 
mixture for the final step of genomic library preparation. Samples were incubated at 25°C for 15 
minutes and subsequently, at 72°C for 5 minutes (SimpliAmp thermal cycler, Life Technologies, 
Monza, Italy) to ligate and nick-repair adapters and barcode to amplicon sequences. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5- Reaction mixture for the initial preparation of the library.  
1 The 79 μL final consist of nuclease-free water and a quantity of amplified 
including. 
Table 6 - Reaction mixture for the preparation of the final genomic library.  
1 X= barcode chosen 
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Finally, library was purified with magnetic beads to obtain a high quality template, free from waste 
products. 
Genomic library was then subjected to an emulsion PCR (emPCR) by means of Ion OneTouch 
TM 400 Template Kit (Life Technologies, Italy). Each library must be diluted to the optimal 
concentration of 26 pM, as low concentrations of sample may produce weak signals, thus leading 
to an inaccurate signal detection; otherwise, an excessive amount of library may generate a huge 
amount of polyclonal sequences and consequently, not analyzable data. The composition of 
emPCR reaction mixture is shown in Table 7. 
 
 
 
 
 
 
 
 
 
 
 
 
Subsequently, samples were enriched through a special purification that favored selection of Ion 
Sphere Particles on which the library amplification reaction occurred. The Ion OneTouch ™ ES 
(Life Technologies, Monza, Italy) allows the complete automatization of enrichment step. 
Reagents used for this step and the specific order they were added in the strip are summarized in 
Table 8 and Table 9, respectively. 
 
 
 
 
 
 
 
Table 7–Emulsion PCR Reaction mixture.  
1 Library final concentration26pM; 2Ion SphereTMParticles 
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3.2.3 Ion Torrent PGM sequencing 
Library sequencing was carried out on a 316 chip by means of Ion Torrent Personal Genome 
Machine (PGM) system, using the IonPGM Hi-Q kit (Life Technologies, Monza Italy). 
Sequencing with Ion Torrent PGM ™ is based on three fundamental steps: Initialization, Chip 
Check and Sequencing. 
Initialization allows the instrument to bring all solutions used in sequencing to the proper pH; this 
is a critical step since Ion technology is based on the measurement of small changes of pH. 
Consequently, it is essential that the initial pH is finely controlled. Preparation of each bottle used 
in the sequencing is reported in Table 10. After having reached the optimal pH, 4 tubes containing 
each one 20 µl of one deoxyribonucleotide (dNTP) (Ion PGM ™ dNTPs Kit, Life Technologies, 
Italy) were installed on the Ion PGM.  
 
 
 
Table 8–Preparation of the Melt-off solution 
Table 9–Preparation of the reagents for the template-
positive enrichment using Ion OneTouch ™ ES (Life 
Technologies) 
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For the primer annealing, 5μl of Control ISPs and 12 μl of Sequencing Primer (Ion PGM™ Hi-
Q™ Sequencing Kit, Life Technologies, Italia) were added directly to the entire volume of 
enriched-template, for a total volume of 27μl; sample was then subjected to an incubation at 95°C 
for 2 minutes, followed by incubation at 37°C for 2 minutes. During the annealing step, the Chip 
Check was performed to test the chip quality and functionality before loading the sample. 
Following the Chip Check, sample was loaded on chip and sequenced. 
At the end of sequencing, reads were filtered by the PGM software to remove low quality and 
polyclonal sequences. Sequences matching the PGM 3′ adaptor were also automatically trimmed. 
16S rRNA sequences were then analyzed by Ion Reporter Software, which comprises a suite of 
bioinformatics tools that streamline and simplify analysis of semiconductor-based sequencing 
data. 16S rRNA workflow module in Ion Reporter Soft is able to classify individual reads 
combining a Basic Local Alignment Search Tool (BLAST) alignment to curated Greengenes 
database, which contains more than 400,000 records, with a BLAST alignment to the premium 
curated MicroSEQ ID database, a high quality library of full-length 16S rRNA sequences. The 
final output of Ion Reporter Software was the identification of microorganisms and their 
abundance in the sample. 
 
3.3 Analysis methods  
Sequencing the human microbiota, we obtain a large amount of data per single subject. 
Consequently, we need several techniques to reduce data set size, as well as to analyze and  
 
Table 10–Composition of Wash1, Wash2 and Wash3 solutions. The Ion 
PGM ™ Hi-Q ™ Sequencing Solution W2 and W3 are provided with the 
kit Ion PGM ™ Hi-Q ™ Sequencing Kit (Life Technologies, Italy) 
 19 
 
3. Materials and Methods   
 
graphically express them, obtaining an immediate visual analysis and a simultaneous interpretation 
of responses in relation to specific variables. 
To date, several methods of analysis are available and divided into: 
- sorting methods; 
- multivariate analyzes based on hypothesis testing. 
Aforementioned methods are used in several scientific fields and on datasets of different nature 
and structure. In order to carry out our analysis, a particular organization of data was considered. 
Indeed, our dataset was a matrix where rows were willing the subjects, while in columns OTU 
count for all bacterial genera identified were arrayed. Therefore, for each subject enrolled in our 
studies, data were microbial abundances, expressed as relative abundance of OTU. 
The sorting methods have descriptive and informative synthesis purpose. They can be divided into 
two main categories: not bound or bound methods. In the first case, they use only information 
referring to genera abundances (or OTU), while bound methods take into account other 
environmental variables associated to dataset (i.e. sex, age and status of the subjects of health, 
etc...). A bound method that is generally applied to investigate a multivariate dataset is the 
Principal Component Analysis (PCA), which combines linearly the variables into dataset to 
explain the maximum variance of initial data using less variables. Differently, multivariate analysis 
(such as hierarchical cluster analysis and biodiversity indices, including Shannon, Simpson and 
Chao’s indices) based on hypothesis testing allow to assess whether differences between subjects 
exist, according to genera abundance values, as well as to represent dataset in a diagram according 
to bacterial similarities. In particular, a hierarchical cluster analysis investigates the associations 
among variables while, the biodiversity indices allow the characterization of microbial community 
composition and the better understanding of their structure and dynamics.  
The analysis methods applied in the present PhD study were selected from those applied mainly 
in literature (for instance, biodiversity analysis, PCA and hierarchical clustering), together with a 
new methodology, the Auto Contractive Map (AutoCM), which is consist in a closed source 
software based on artificial neural network and may be very useful to investigate the human 
microbiota.
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LIST OF MANUSCRIPTS  
Manuscript 1 
Persisting changes of intestinal microbiota after bowel lavage and colonoscopy 
Published in European Journal of Gastroenterology & Hepatology 
 
Introduction 
The aim of this study was to evaluate the effects of standard bowel lavage on the gut microbiota 
composition of healthy individuals undergoing to colonoscopy. Fecal bacterial composition was 
investigated immediately after the bowel cleansing and 1 month after the colonoscopy in order to 
establish whether this treatment could have long-lasting effects on the intestinal environment. 
 
Main Results 
The gut microbiota of individuals subjected to colonoscopy did not completely return to the 
composition before the colonoscopy. One month after the bowel cleansing, indeed, Firmicutes 
have been observed to be less abundant, while Proteobacteria abundance showed a significant 
increase if compared with samples collected before the examination. 
 
Breakthrough  
In this first study, we applied a simply relative abundance analysis to investigate microbiota 
modifications at phyla, class and family level. Even if several significant changes were observed, 
we understood how extremely complex metagenomics data are, especially regarding their high 
variability. 
 
